Schedule 13G ownership disclosure

TRILLIUM THERAPEUTICS INC COM NEW

Security class unavailable · CUSIP: 89620X506

Event date: 2020-01-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
820,940
Percent of class
1.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-20-002392
Form type
SC 13G
Filer
Trillium Therapeutics Inc.
CIK
CIK 1616212
Filed
Feb 03, 2020
Reporting period
Jan 27, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub